SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001213900-21-055322
Filing Date
2021-10-29
Accepted
2021-10-29 13:29:57
Documents
137

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs42021a2_cmlifesci3.htm   iXBRL S-4/A 14917055
2 SPECIMEN CLASS A COMMON STOCK CERTIFICATE fs42021a2ex4-1_cmlifesci3.htm EX-4.1 14588
3 OPINION OF WHITE & CASE LLP AS TO THE VALIDITY OF THE SECURITIES BEING REGISTERE fs42021a2ex5-1_cmlifesci3.htm EX-5.1 8024
4 EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN EQRX, INC. AND G1 THERAPEUTICS, INC. fs42021a2ex10-34_cmlifesci3.htm EX-10.34 631696
5 LICENSE AGREEMENT BY AND BETWEEN EQRX, INC. AND CSTONE PHARMACEUTICALS DATED OCT fs42021a2ex10-35_cmlifesci3.htm EX-10.35 373453
6 CONSENT OF ERNST & YOUNG LLP fs42021a2ex23-2_cmlifesci3.htm EX-23.2 1933
7 FORM OF PRELIMINARY PROXY CARD fs42021a2ex99-1_cmlifesci3.htm EX-99.1 1611
8 CONSENT OF HOULIHAN LOUKEY CAPITAL, INC fs42021a2ex99-11_cmlifesci3.htm EX-99.11 6269
9 GRAPHIC teqrx_logo.jpg GRAPHIC 702720
10 GRAPHIC teqrxstand_001.jpg GRAPHIC 1004746
11 GRAPHIC tmission_001.jpg GRAPHIC 1420356
12 GRAPHIC tglance_001.jpg GRAPHIC 1484773
13 GRAPHIC tletter_001.jpg GRAPHIC 197583
14 GRAPHIC timage_021.jpg GRAPHIC 382158
15 GRAPHIC timage_002.jpg GRAPHIC 605466
16 GRAPHIC timage_003.jpg GRAPHIC 585535
17 GRAPHIC timage_004.jpg GRAPHIC 503201
18 GRAPHIC timage_005.jpg GRAPHIC 2184803
19 GRAPHIC timage_006.jpg GRAPHIC 518500
20 GRAPHIC timage_007.jpg GRAPHIC 452546
21 GRAPHIC timage_022.jpg GRAPHIC 630693
22 GRAPHIC timage_009.jpg GRAPHIC 451289
23 GRAPHIC timage_010.jpg GRAPHIC 629346
24 GRAPHIC timage_011.jpg GRAPHIC 600409
25 GRAPHIC timage_012.jpg GRAPHIC 588564
26 GRAPHIC teqrx_logored.jpg GRAPHIC 706221
27 GRAPHIC teqrx_red.jpg GRAPHIC 679639
28 GRAPHIC ex99-1_001.jpg GRAPHIC 323260
29 GRAPHIC ex99-1_002.jpg GRAPHIC 180537
  Complete submission text file 0001213900-21-055322.txt   63433696

Data Files

Seq Description Document Type Size
30 XBRL SCHEMA FILE cmlt-20210630.xsd EX-101.SCH 148795
31 XBRL CALCULATION FILE cmlt-20210630_cal.xml EX-101.CAL 36928
32 XBRL DEFINITION FILE cmlt-20210630_def.xml EX-101.DEF 659314
33 XBRL LABEL FILE cmlt-20210630_lab.xml EX-101.LAB 913500
34 XBRL PRESENTATION FILE cmlt-20210630_pre.xml EX-101.PRE 644661
35 EXTRACTED XBRL INSTANCE DOCUMENT fs42021a2_cmlifesci3_htm.xml XML 3777151
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-259054 | Film No.: 211362122
SIC: 2834 Pharmaceutical Preparations